Whitehawk Therapeutics, Inc. (NasdaqCM: WHWK)
Health Care · Biotechnology · US
$4.73
+6.05% today · +178.2% 1Y
Whitehawk Therapeutics, Inc. (NasdaqCM: WHWK) operates in the Biotechnology industry within the Health Care sector. The company is valued at $269.65M and employs 29 people.
Over the last twelve months the share price has gained 178.2%, trading between 1.68 and 5.50.
Tweenvest scores Whitehawk Therapeutics, Inc. across four factors: quality 26/100, growth 0/100. Its strongest factor is quality.
WHWK price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $269.65M
- Revenue (TTM)
- $0.00
- P/E
- —
- EPS
- -1.10
- Dividend yield
- —
- Beta (5Y)
- 0.78
- 52-week high
- $5.50
- 52-week low
- $1.68
- Avg volume (3M)
- —
- Shares outstanding
- 57.01M
- Employees
- 29
- Next earnings
- —
About Whitehawk Therapeutics, Inc.
Whitehawk Therapeutics Inc. is a biopharmaceutical enterprise currently undergoing clinical trials. This company specializes in crafting highly targeted treatment options for cancers that are identified by distinct genetic profiles.
- Founded
- 2007
- Listed since
- Aug 1, 2017
- Exchange
- Nasdaq Capital Market
- Currency
- USD
Other Biotechnology companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| AbbVie Inc.NYSE: ABBV | $468.22B | $264.96 | +1.20% |
| Amgen Inc.NasdaqGS: AMGN | $237.52B | $439.33 | +1.29% |
| Gilead Sciences, Inc.NasdaqGS: GILD | $181.18B | $146.12 | +1.86% |
| Vertex Pharmaceuticals IncorporatedNasdaqGS: VRTX | $138.91B | $548.05 | +1.44% |
| Regeneron Pharmaceuticals, Inc.NasdaqGS: REGN | $83.28B | $834.04 | +0.90% |
| argenx SEENXTBR: ARGX | $65.85B | €902.00 | +1.90% |
| Moderna, Inc.NasdaqGS: MRNA | $57.92B | $145.13 | +0.04% |
| CSL LimitedASX: CSL | $57.77B | AU$168.30 | -1.69% |
Figures last refreshed Aug 18, 2026.